FeesSafety
Pluang+

DBV submits BLA for VIASKIN Peanut in kids 4-7, cash funds operations into Q3 2027 amid manufacturing fixes.

Market News
18 Nov 2026, 21:45 WIB
The Motley Fool
View Source
Neutral
DBV submits BLA for VIASKIN Peanut in kids 4-7, cash funds operations into Q3 2027 amid manufacturing fixes.

DBV Technologies has submitted its Biologics License Application (BLA) for VIASKIN Peanut targeting children aged 4 to 7 years, marking a key step toward commercial approval. The company is addressing manufacturing quality issues at its contract manufacturer, Fareva Amboise, which received an FDA Warning Letter, and is sequencing regulatory filings to avoid review delays. With $165.7 million in cash, DBV is managing spending based on regulatory milestones to sustain operations into the third quarter of 2027. Management plans to submit a BLA for toddlers next year and is preparing for potential commercialization while balancing investment and capital discipline.

DBV Technologies is highlighted here with a focus on its regulatory and financial strategy. For readers following the health sector, here is Pluang's market snapshot as of Nov 19, 2026 02:21 WIB: out of 150 priced US health stocks, 71 rose and 78 fell. Notable movers include ABEO at USD 2.75 (+5.96%) with 94% sell activity, DVA at USD 162.71 (-5.95%) with 98% sell activity, and BFLY at USD 6.08 (+5.74%).

More News

Bristol-Myers Squibb raises 2026 earnings forecast as new drug sales grow 12%

Bristol-Myers Squibb raises 2026 earnings forecast as new drug sales grow 12%

Bristol-Myers Squibb increased its full-year 2026 earnings guidance following a 12% revenue growth in its growth portfolio to $7.7 billion, driven by eight medicines each generating over $1 billion annually. The company is offsetting losses from pate...

Company Fundamentals
Bullish
55 minutes ago
Restaurant Brands posts strong Q3 sales growth, international expansion, and improved debt ratings.

Restaurant Brands posts strong Q3 sales growth, international expansion, and improved debt ratings.

Restaurant Brands reported 6.2% systemwide sales growth and 6.7% organic operating income growth in Q3 2026, driven by Burger King's U.S. same-store sales rising 8.4% and Popeyes expanding to over 2,000 international locations with $2 billion in sale...

Company Fundamentals
Bullish
55 minutes ago
Silgan plans to split into two companies after acquiring Trivium, raising full-year EPS forecast.

Silgan plans to split into two companies after acquiring Trivium, raising full-year EPS forecast.

Silgan announced it will acquire Trivium and separate into two independent packaging companies: Silgan Dispensing Solutions, focusing on high-growth dispensing products, and Silgan Metal Container Corporation, specializing in food packaging. Despite ...

Company Fundamentals
Bullish
55 minutes ago
Gladstone Capital's net investment income rises to $11M in Q4 2026, driven by equity gains and variable rate loans.

Gladstone Capital's net investment income rises to $11M in Q4 2026, driven by equity gains and variable rate loans.

Gladstone Capital reported net investment income of $11 million for Q4 fiscal 2026, supported by a focus on lower middle market lending and disciplined credit terms. The company’s equity investments generated $64.2 million in gains over five years, o...

Company Fundamentals
Bullish
1 hour ago
Voyage revenues soar 249% in Q3 2026 as C3is expands fleet and boosts earnings.

Voyage revenues soar 249% in Q3 2026 as C3is expands fleet and boosts earnings.

C3is reported a 249% increase in voyage revenues to $16.7 million for Q3 2026, driven by higher charter rates and a larger fleet including two new product tankers. The company achieved a 1,300% rise in adjusted net income for the first nine months, r...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App